18
Discover us

03 July 2025

The recording of our June 24 opnMe seminar is now available for streaming. Discover how academic researchers used an elegant screening approach, using tools from open innovation platforms such as opnMe, and uncovered a novel fundamental mechanism promoting pancreatic cancer progression. By leveraging BI 653048, opnMe’s well-characterized glucocorticoid receptor agonist, they identified the glucocorticoid receptor as a key player in specific pancreatic cancer subtypes.

57
Discover us

18 June 2025

Boehringer Ingelheim scientists have analysed and published on the impact of structural variants (SVs) on traits related to respiratory, cardiometabolic and liver diseases. Now we make key data of that study1 available through the opnMe portal to allow unrestricted access by researchers to advance knowledge of genetic variation in the human population.

31
Discover us

5 June 2025

Discover how open science and free access to high-quality chemical probes helped Steven Johnsen and Thomas Ekstrom at the Robert Bosch Center for Tumor Diseases in Stuttgart / Germany uncover new insights into transcriptional regulation in pancreatic cancer. Read the full interview and get inspired for your own research.

14
PostDoc Grants

19 May 2025

Assessing the environmental persistence of active pharmaceutical ingredients (APIs) is crucial for minimizing the ecological footprint across every stage of a medicine's lifecycle. Boehringer Ingelheim Animal Health prioritizes sustainability by integrating frameworks like Safe and Sustainable by Design (SSbD) and Green Chemistry Principles into parasiticide drug design, mirroring human pharmaceutical development processes encompassing hit finding, lead optimization, and candidate development.

120
Discover us

09 April 2025

Watch the recording of our online seminar and learn how open science supports scientific careers and fosters new research collaborations. Hear inspiring success stories from two young scientists who have advanced their research and careers in nanoformulation and organ-on-a-chip technology through opnMe.

Discover us

Hear from our collaborators

slide 1 to 2 of 13